Cardiac biomarkers market size to grow by USD 7,880.86 million from 2022 to 2027: Increasing prevalence of CVDs to drive growth - Technavio

NEW YORK, March 15, 2023 /PRNewswire/ -- The global cardiac biomarkers market size is estimated to increase by USD 7,880.86 million from 2022 to 2027. The market's growth momentum will accelerate at a CAGR of 12.6%. The increase in the prevalence of CVDs (cardio vascular diseases) is driving the market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people aged 40 years and above in the US had the peripheral arterial disease (PAD) in 2021. Factors such as low awareness, especially in the growing economies of Asia, are the main reasons for the high prevalence of this disease. Other risk factors include smoking, a high prevalence of cardiac arrhythmias, atherosclerosis, diabetes, and high cholesterol. Therefore, the demand for cardiac biomarkers is expected to increase during the forecast period. Discover some insights on market size, historic period (2017 to 2021), and forecast period (2023 to 2027) before buying the full report - Request a sample report

Cardiac biomarkers market – Vendor analysis
Vendor landscape –

The global cardiac biomarkers market is fragmented, with the presence of several vendors. A few prominent vendors that offer cardiac biomarkers in the market are Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., AgPlus Diagnostics Ltd., and Tosoh Corp.

The market provides various growth opportunities for vendors. They are engaging in M&A to strengthen their position in the global cardiac biomarkers market. Vendors are also increasing their R&D investments to develop technologically advanced cardiac biomarkers. They are also implementing innovative strategies to remain competitive in the market, such as strategic alliances with other companies. All these factors will intensify competition among vendors during the forecast period.

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/active/niche/trivial - Buy the report!

Vendor offerings -

• Abbott Laboratories - The company offers cardiac biomarker solutions such as BNP, CK MB, Galectin 3, Myoglobin, and Troponin I.
• Bio Rad Laboratories Inc. - The company offers cardiac biomarker solutions such as Galectin 3 and BNP NT proBNP.
• bioMerieux SA - The company offers cardiac biomarker solutions such as Liquichek Cardiac Markers Plus Control LT.
• Boditech Med Inc. - The company offers cardiac biomarker solutions such as the VIDAS Acute Coronary Syndrome panel.
• For details on vendors and their offerings – Request a sample report

Cardiac biomarkers market - Segmentation assessment

Segment overview
Technavio has segmented the market based on technology (conventional laboratory testing and POC testing), product (troponin, BNP and NT-proBNP, CK-MB, myoglobin, and others), and end-user (hospitals, clinics, and diagnostic laboratories). 

• The conventional laboratory testing segment will account for a significant share of the market growth during the forecast period. In this type of testing, a clinician takes a sample of bodily fluid or tissue from the patient and then ensures its packaging and transport. The sample is then shipped to a central laboratory, where it is analyzed by a professional. The long time taken for this process, owing to the need for proper packaging and shipping, lab capacity, test processing, and data sharing may decline the growth of this segment during the forecast period.

Geography overview
Based on geography, the global cardiac biomarkers market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global cardiac biomarkers market.

• North America is estimated to account for 40% of the growth of the global market during the forecast period. The US and Canada are the key countries in the region. Factors such as high healthcare expenditure, an increasing number of new product approvals, and the rising adoption of technologically advanced cardiac biomarkers are driving the growth of the regional market. Public and private organizations in North America are taking initiatives to increase awareness about CVDs, which will increase funding for research on cardiac biomarkers.

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a sample report

Cardiac biomarkers market – Market dynamics

Key trends – The increasing focus on personalized medicine is a key trend in the market. The demand for personalized medicine will increase, with the development of genome technology, whole genome testing technology, and companion diagnostics. This will, in turn, drive the demand for diagnostic procedures. For instance, the use of a blood-based biomarker may help predict the efficacy of treatments for preventing myocardial infarction in high-risk patients. Such information is crucial for developing personalized therapies for curing or treating heart-related diseases. Thus, the growing focus on personalized medicine is expected to drive the growth of the market.

Major challenges - A shortage of skilled clinicians is challenging the market growth. Skilled cardiologists are required to perform safe and effective cardiac procedures and diagnose heart diseases. However, there is a shortage of cardiologists globally, including in developed countries. This is due to trends such as consolidation among healthcare organizations, new maintenance of certification (MOC) requirements, reduction in funding for Graduate Medical Education (GME) and research, and a decline in physician reimbursements. In several developing countries, access to cardiovascular care is limited.

Trends and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this cardiac biomarkers market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the cardiac biomarkers market between 2023 and 2027
• Precise estimation of the size of the cardiac biomarkers market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the cardiac biomarkers market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of cardiac biomarkers market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The cardiac rehabilitation market is estimated to grow at a CAGR of 6.9% between 2022 and 2027. The size of the market is forecasted to increase by USD 1,953.85 million. The reforming healthcare systems in emerging countries are notably driving the market growth, although factors such as lack of access in LMICs may impede the market growth.

The predicted growth for the cardiac monitoring and cardiac rhythm management devices market size from 2021 to 2026 is USD 5.52 billion at a progressing CAGR of 4.5%. The increasing prevalence of CVDs is notably driving the cardiac monitoring and cardiac rhythm management devices market growth, although factors such as the high costs of CM and CRM devices may impede the market growth.

Browse for Technavio Health Care Market reports

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 08: Executive Summary – Chart on Incremental Growth
• Exhibit 09: Executive Summary – Data Table on Incremental Growth
• Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 11: Parent market
• Exhibit 12: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 13: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 14: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global cardiac biomarkers market 2017 - 2021
• Exhibit 19: Historic Market Size – Data Table on Global cardiac biomarkers market 2017 - 2021 ($ million)

• 4.2 Technology Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 End-user Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.5 Geography Segment Analysis 2017 - 2021 
• Exhibit 23: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.6 Country Segment Analysis 2017 - 2021 
• Exhibit 24: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 25: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology

• 6.1 Market segments 
• Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
• Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)

• 6.2 Comparison by Technology 
• Exhibit 34: Chart on Comparison by Technology
• Exhibit 35: Data Table on Comparison by Technology

• 6.3 Conventional laboratory testing - Market size and forecast 2022-2027 
• Exhibit 36: Chart on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 37: Data Table on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 38: Chart on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
• Exhibit 39: Data Table on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)

• 6.4 POC testing - Market size and forecast 2022-2027
• Exhibit 40: Chart on POC testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 41: Data Table on POC testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 42: Chart on POC testing - Year-over-year growth 2022-2027 (%)
• Exhibit 43: Data Table on POC testing - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Technology 
• Exhibit 44: Market opportunity by Technology ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 45: Chart on Product - Market share 2022-2027 (%)
• Exhibit 46: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 47: Chart on Comparison by Product
• Exhibit 48: Data Table on Comparison by Product

• 7.3 Troponin - Market size and forecast 2022-2027
• Exhibit 49: Chart on Troponin - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Data Table on Troponin - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Chart on Troponin - Year-over-year growth 2022-2027 (%)
• Exhibit 52: Data Table on Troponin - Year-over-year growth 2022-2027 (%)

• 7.4 BNP and NT-proBNP - Market size and forecast 2022-2027
• Exhibit 53: Chart on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Data Table on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
• Exhibit 55: Chart on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
• Exhibit 56: Data Table on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)

• 7.5 CK-MB - Market size and forecast 2022-2027
• Exhibit 57: Chart on CK-MB - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Data Table on CK-MB - Market size and forecast 2022-2027 ($ million)
• Exhibit 59: Chart on CK-MB - Year-over-year growth 2022-2027 (%)
• Exhibit 60: Data Table on CK-MB - Year-over-year growth 2022-2027 (%)

• 7.6 Myoglobin - Market size and forecast 2022-2027
• Exhibit 61: Chart on Myoglobin - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on Myoglobin - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on Myoglobin - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on Myoglobin - Year-over-year growth 2022-2027 (%)

• 7.7 Others - Market size and forecast 2022-2027
• Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Product 
• Exhibit 69: Market opportunity by Product ($ million)

8 Market Segmentation by End-user

• 8.1 Market segments 
• Exhibit 70: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 71: Data Table on End-user - Market share 2022-2027 (%)

• 8.2 Comparison by End-user 
• Exhibit 72: Chart on Comparison by End-user
• Exhibit 73: Data Table on Comparison by End-user

• 8.3 Hospitals and clinics - Market size and forecast 2022-2027 
• Exhibit 74: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 77: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)

• 8.4 Diagnostic laboratories - Market size and forecast 2022-2027 
• Exhibit 78: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 81: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)

• 8.5 Market opportunity by End-user 
• Exhibit 82: Market opportunity by End-user ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview 
• Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation 
• Exhibit 84: Chart on Market share by geography 2022-2027 (%)
• Exhibit 85: Data Table on Market share by geography 2022-2027 (%)

• 10.2 Geographic comparison 
• Exhibit 86: Chart on Geographic comparison
• Exhibit 87: Data Table on Geographic comparison

• 10.3 North America - Market size and forecast 2022-2027
• Exhibit 88: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 91: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 10.4 Europe - Market size and forecast 2022-2027
• Exhibit 92: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 95: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 10.5 Asia - Market size and forecast 2022-2027
• Exhibit 96: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 99: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 10.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 100: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 103: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 10.7 US - Market size and forecast 2022-2027
• Exhibit 104: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 107: Data Table on US - Year-over-year growth 2022-2027 (%)

• 10.8 Germany - Market size and forecast 2022-2027
• Exhibit 108: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 111: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 10.9 China - Market size and forecast 2022-2027
• Exhibit 112: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 114: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 115: Data Table on China - Year-over-year growth 2022-2027 (%)

• 10.10 UK - Market size and forecast 2022-2027
• Exhibit 116: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 117: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 118: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 119: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 10.11 India - Market size and forecast 2022-2027
• Exhibit 120: Chart on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 121: Data Table on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 122: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 123: Data Table on India - Year-over-year growth 2022-2027 (%)

• 10.12 Market opportunity by geography 
• Exhibit 124: Market opportunity by geography ($ million)

11 Drivers, Challenges, and Trends

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges 
• Exhibit 125: Impact of drivers and challenges in 2022 and 2027

• 11.4 Market trends

12 Vendor Landscape

• 12.1 Overview

• 12.2 Vendor landscape 
• Exhibit 126: Overview on Criticality of inputs and Factors of differentiation

• 12.3 Landscape disruption 
• Exhibit 127: Overview on factors of disruption

• 12.4 Industry risks 
• Exhibit 128: Impact of key risks on business

13 Vendor Analysis

• 13.1 Vendors covered 
• Exhibit 129: Vendors covered

• 13.2 Market positioning of vendors 
• Exhibit 130: Matrix on vendor position and classification

• 13.3 Abbott Laboratories 
• Exhibit 131: Abbott Laboratories - Overview
• Exhibit 132: Abbott Laboratories - Business segments
• Exhibit 133: Abbott Laboratories - Key news
• Exhibit 134: Abbott Laboratories - Key offerings
• Exhibit 135: Abbott Laboratories - Segment focus

• 13.4 BG Medicine Inc. 
• Exhibit 136: BG Medicine Inc. - Overview
• Exhibit 137: BG Medicine Inc. - Product / Service
• Exhibit 138: BG Medicine Inc. - Key offerings

• 13.5 Bio Rad Laboratories Inc. 
• Exhibit 139: Bio Rad Laboratories Inc. - Overview
• Exhibit 140: Bio Rad Laboratories Inc. - Business segments
• Exhibit 141: Bio Rad Laboratories Inc. - Key news
• Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 143: Bio Rad Laboratories Inc. - Segment focus

• 13.6 bioMerieux SA 
• Exhibit 144: bioMerieux SA - Overview
• Exhibit 145: bioMerieux SA - Product / Service
• Exhibit 146: bioMerieux SA - Key news
• Exhibit 147: bioMerieux SA - Key offerings

• 13.7 Boditech Med Inc. 
• Exhibit 148: Boditech Med Inc. - Overview
• Exhibit 149: Boditech Med Inc. - Key offerings

• 13.8 Creative Diagnostics 
• Exhibit 150: Creative Diagnostics - Overview
• Exhibit 151: Creative Diagnostics - Product / Service
• Exhibit 152: Creative Diagnostics - Key offerings

• 13.9 Diazyme Laboratories Inc. 
• Exhibit 153: Diazyme Laboratories Inc. - Overview
• Exhibit 154: Diazyme Laboratories Inc. - Product / Service
• Exhibit 155: Diazyme Laboratories Inc. - Key offerings

• 13.10 F. Hoffmann La Roche Ltd. 
• Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus

• 13.11 Lepu Medical Technology Beijing Co. Ltd.
• Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. - Overview
• Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
• Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. - Key offerings

• 13.12 LifeSign LLC 
• Exhibit 164: LifeSign LLC - Overview
• Exhibit 165: LifeSign LLC - Product / Service
• Exhibit 166: LifeSign LLC - Key offerings

• 13.13 LSI Medience Corp. 
• Exhibit 167: LSI Medience Corp. - Overview
• Exhibit 168: LSI Medience Corp. - Product / Service
• Exhibit 169: LSI Medience Corp. - Key offerings

• 13.14 Randox Laboratories Ltd. 
• Exhibit 170: Randox Laboratories Ltd. - Overview
• Exhibit 171: Randox Laboratories Ltd. - Product / Service
• Exhibit 172: Randox Laboratories Ltd. - Key offerings

• 13.15 Response Biomedical Corp. 
• Exhibit 173: Response Biomedical Corp. - Overview
• Exhibit 174: Response Biomedical Corp. - Product / Service
• Exhibit 175: Response Biomedical Corp. - Key offerings

• 13.16 Siemens Healthineers AG 
• Exhibit 176: Siemens Healthineers AG - Overview
• Exhibit 177: Siemens Healthineers AG - Business segments
• Exhibit 178: Siemens Healthineers AG - Key news
• Exhibit 179: Siemens Healthineers AG - Key offerings
• Exhibit 180: Siemens Healthineers AG - Segment focus

• 13.17 Signosis Inc. 
• Exhibit 181: Signosis Inc. - Overview
• Exhibit 182: Signosis Inc. - Product / Service
• Exhibit 183: Signosis Inc. - Key offerings

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist 
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist

• 14.3 Currency conversion rates for US$ 
• Exhibit 186: Currency conversion rates for US$

• 14.4 Research methodology 
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources

• 14.5 List of abbreviations 
• Exhibit 190: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio